摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

睾酮 10-十一碳烯酸酯 | 29430-26-0

中文名称
睾酮 10-十一碳烯酸酯
中文别名
睾酮10-十一碳烯酸酯
英文名称
17β-undec-10-enoyloxy-androst-4-en-3-one
英文别名
17β-Undec-10-enoyloxy-androst-4-en-3-on;17β-hydroxyandrost-4-en-3-one undecenoate;Testosterone undecylenate;[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undec-10-enoate
睾酮 10-十一碳烯酸酯化学式
CAS
29430-26-0
化学式
C30H46O3
mdl
——
分子量
454.693
InChiKey
PBFYIQCFOZXSKC-CNQKSJKFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    氯仿(少量溶解)、DMSO(少量溶解)、乙酸乙酯(少量溶解)、甲醇(少量溶解)

计算性质

  • 辛醇/水分配系数(LogP):
    8
  • 重原子数:
    33
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:b5c971c610e452ce31c0406bb279d55c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    睾酮 10-十一碳烯酸酯iron(II) acetylacetonate 作用下, 以 叔丁醇 为溶剂, 反应 24.0h, 以64%的产率得到(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopentaphenanthren-17-yl 10-oxoundecanoate
    参考文献:
    名称:
    使用铁催化剂和环境空气的瓦克型氧化:在复杂分子后期氧化中的应用
    摘要:
    空气中:通过使用1 atm的空气作为唯一的氧化剂,已经开发了一种方便且通用的铁催化的内烯烃,缺电子烯烃和苯乙烯氧化为酮的方法。该方案可在温和的反应条件下有效地将大气中的O 2掺入合成有用的化合物中,从而使其对环境无害,经济且操作简单。
    DOI:
    10.1002/anie.201707006
  • 作为产物:
    参考文献:
    名称:
    Gould et al., Journal of the American Chemical Society, 1957, vol. 79, p. 4472,4474
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Zinc-Mediated Intermolecular Reductive Radical Fluoroalkylsulfination of Unsaturated Carbon-Carbon Bonds with Fluoroalkyl Bromides and Sulfur Dioxide
    作者:Yongan Liu、Qiongzhen Lin、Zhiwei Xiao、Changge Zheng、Yong Guo、Qing-Yun Chen、Chao Liu
    DOI:10.1002/chem.201805526
    日期:2019.2.1
    general zinc‐mediated intermolecular reductive radical fluoroalkylsulfination of unsaturated C−C bonds has been developed using readily available fluoroalkyl bromides and 1,4‐diazabicyclo[2.2.2]octane‐bis(sulfur dioxide) adduct (DABSO) with wide substrate scope and excellent functional group tolerance. Sulfur dioxide anion radical generated in situ from the reduction of sulfur dioxide with zinc may be
    使用易于获得的氟代烷基溴和具有宽底物的1,4-二氮杂双环[2.2.2]辛烷-双(二氧化硫)加合物,开发了一种通用且通用的锌介导的不饱和C-C间分子间还原性自由基氟代烷基硫化物。范围和出色的功能组耐受性。由锌还原二氧化硫而原位产生的二氧化硫阴离子自由基可能参与了反应机理。
  • A Predictably Selective Nitration of Olefin with Fe(NO<sub>3</sub>)<sub>3</sub> and TEMPO
    作者:Togati Naveen、Soham Maity、Upendra Sharma、Debabrata Maiti
    DOI:10.1021/jo400598p
    日期:2013.6.21
    Ferric nitrate with catalytic TEMPO has been identified as a useful reagent for regio- and stereoselective nitration of a wide variety of aromatic, aliphatic, and heteroaromatic olefins. This reaction provided nitroolefins in preparatively useful yields with excellent E-selectivity. Due to its mild nature and operational simplicity, the present protocol is expected to find application in synthetic setup.
  • 10-undecenoate of testosterone
    申请人:SYNTEX SA
    公开号:US02826593A1
    公开(公告)日:1958-03-11
  • Yamada, Journal of the Medical Society of Toho University, 1959, vol. 6, p. 481,485
    作者:Yamada
    DOI:——
    日期:——
  • SYSTEM AND METHODS FOR DELIVERING TESTOSTERONE REPLACEMENT DRUG THERAPIES
    申请人:Amarasekera Channa
    公开号:US20220105263A1
    公开(公告)日:2022-04-07
    The present disclosure relates generally to the administration of testosterone replacement therapy, and more particularly to a system and methods for monitoring and analyzing testosterone levels of a patient for dynamically controlling and/or managing delivery of testosterone. The system may include an implantable medical device including a pumping mechanism operatively coupled to an analyte sensor. The analyte sensor may collect a patient's testosterone levels and communicate that information to the pumping mechanism. Based on the information collected by the analyte sensor, the pumping mechanism may deliver one or more testosterone replacement drug therapies to the patient. Advantageously, the system may automatically regulate the delivery of said one or more testosterone replacement drug therapies based on a testosterone level of the patient, while minimizing patient oversight of the administration process and reducing discomfort.
查看更多